NDC 0338-0067 – Doxil
Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Intravitreal
Product NDC0338-0067
Product details
- Brand name
- Doxil
- Generic name
- Doxorubicin hydrochloride
- Labeler
- Baxter Healthcare Company
- Dosage form
- Injection, Suspension, Liposomal
- Route
- Intravitreal
- Marketing category
- NDA · NDA050718
- Marketed since
- August 13, 2019
- Listing expires
- December 31, 2027
- Pharmacologic class
- Anthracycline Topoisomerase Inhibitor
Active ingredients
- Doxorubicin Hydrochloride 2 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0338-0067-01 | 1 VIAL, SINGLE-USE in 1 CARTON (0338-0067-01) / 25 mL in 1 VIAL, SINGLE-USE | Aug 13, 2019 |
Recalls mentioning this NDC
- D-0048-2024 Oct 25, 2023 · Class II
CGMP Deviations: Product was exposed to temperatures exceeding the labeled storage conditions during transportation were released by mistake.
Other Doxil products
- 0338-0063 Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Baxter Healthcare Company
- 0338-9665 Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Baxter Healthcare Corporation
- 0338-9667 Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Baxter Healthcare Corporation